Analystreport

Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.50 to $3.25. They now have a "neutral" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report